References
- Yoon SY , OhJ. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J. Intern. Med.33(6), 1058–1069 (2018).
- Edwards HL , MulveyMR , BennettMI. Cancer-related neuropathic pain. Cancers (Basel)11(3), 373 (2019).
- Seretny M , CurrieGL , SenaESet al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain155(12), 2461–2470 (2014).
- Zajaczkowską R , Kocot-KępskaM , LeppertW , WrzosekA , MikaJ , WordliczekJ. Mechanisms of chemotherapy-induced peripheral neuropathy. Int. J. Mol. Sci.20(6), 1451 (2019).
- Staff NP , GrisoldA , GrisoldW , WindebankAJ. Chemotherapy-induced peripheral neuropathy: a current review. Ann. Neurol.81(6), 772–781 (2017).
- Park SB , GoldsteinD , KrishnanAVet al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J. Clin.63(6), 419–437 (2013).
- Gutiérrez-Gutiérrez G , SerenoM , MirallesA , Casado-SáenzE , Gutiérrez-RivasE. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin. Transl. Oncol.12(2), 81–91 (2010).
- Grisold W , CavalettiG , WindebankAJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro. Oncol.14, 45–54 (2012).
- Ibrahim EY , EhrlichBE. Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings. Crit. Rev. Oncol. Hematol.145(102831), (2020).
- Hershman DL , LacchettiC , DworkinRHet al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american society of clinical oncology clinical practice guideline. J. Clin. Oncol.32(18), 1941–1967 (2014).
- Kautio AL , HaanpääM , SaartoT , KalsoE. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J. Pain Symptom Manage.35(1), 31–39 (2008).
- de Andrade DC , JacobsenTeixeira M , GalhardoniRet al. Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a randomized, double-blind trial. Oncologist.29(7), 2601–2606 (2017).
- Hammack JE , MichalakJC , LoprinziCLet al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain98(1–2), 195–203 (2002).
- Hou S , HuhB , KimHK , KimKH , AbdiS. Treatment of chemotherapy-induced peripheral neuropathy: systematic review and recommendations. Pain Physician.21(6), 571–592 (2018).
- Rao RD , MichalakJC , SloanJAet al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy. Cancer110(9), 2110–2118 (2007).
- Kautio AL , HaanpääM , LeminenA , KalsoE , KautiainenH , SaartoT. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. Anticancer Res.29(7), 2601–2606 (2009).
- Hu L-Y , MiW-L , WuG-C , WangY-Q , Mao-YingQ-L. Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms. Curr. Neuropharmacol.17(2), 184–196 (2018).
- Rao RD , FlynnPJ , SloanJAet al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer112(12), 2802–2808 (2008).
- Baek H , PahkKJ , KimH. A review of low-intensity focused ultrasound for neuromodulation. Biomed. Eng. Lett.7(2), 135–142 (2017).
- Bauer R , MartinE , Haegele-LinkS , KaegiG , von SpechtM , WernerB. Noninvasive functional neurosurgery using transcranial MR imaging-guided focused ultrasound. Park. Relat. Disord.20(1), S197–S199 (2014).
- Rezayat E , ToostaniIG. A review on brain stimulation using low intensity focused ultrasound. Basic Clin. Neurosci.7(3), 187–194 (2016).
- Haffey PR , BansalN , KayeEet al. The regenerative potential of therapeutic ultrasound on neural tissue: a pragmatic review. Pain Med.21(7), 1494–1506 (2020).
- Chen WZ , QiaoH , ZhouW , WuJ , WangZB. Upgraded nerve growth factor expression induced by low-intensity continuous-wave ultrasound accelerates regeneration of neurotometicly injured sciatic nerve in rats. Ultrasound Med. Biol.36(7), 1109–1117 (2010).
- Ni XJ , WangXD , ZhaoYHet al. The effect of low-intensity ultrasound on brain-derived neurotropic factor expression in a rat sciatic nerve crushed injury model. Ultrasound Med. Biol.43(2), 461–468 (2017).
- Liu F , XuanA , ChenYet al. Combined effect of nerve growth factor and brain-derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol. Med. Rep.10(4), 1739–1745 (2014).
- Wang R , YanF , LiaoR , WanP , LittlePJ , ZhengW. Role of brain-derived neurotrophic factor and nerve growth factor in the regulation of neuropeptide W in vitro and in vivo. Mol. Cell. Endocrinol.447, 71–78 (2017).
- Ebenbichler GR , ReschKL , NicolakisPet al. Ultrasound treatment for treating the carpal tunnel syndrome: randomised “sham” controlled trial. Br. Med. J.316(7133), 731–735 (1998).
- Bakhtiary AH , Rashidy-PourA. Ultrasound and laser therapy in the treatment of carpal tunnel syndrome. Aust. J. Physiother.50(3), 147–151 (2004).
- Paoloni M , TaverneseE , CacchioAet al. Extracorporeal shock wave therapy and ultrasound therapy improve pain and function in patients with carpal tunnel syndrome. A randomized controlled trial. Eur. J. Phys. Rehabil. Med.51(5), 521–528 (2015).
- Oztas O , TuranB , BoraI , KarakayaMK. Ultrasound therapy effect in carpal tunnel syndrome. Arch. Phys. Med. Rehabil.79(12), 1540–1544 (1998).
- Kotb MA , DarwishAF. Comparison of splinting plus local steroid injection, and splinting plus ultrasound and low-level laser therapy outcomes in idiopathic mild to moderate carpal tunnel syndrome. Egypt. J. Neurol. Psychiatry Neurosurg.51(4), 451–458 (2014).
- Al Onazi MM , YurickJ , HarrisCet al. Therapeutic ultrasound for chemotherapy-related pain and sensory disturbance in the hands and feet in patients with colorectal cancer: a pilot randomized controlled trial. J. Pain Symptom Manage.S0885-3924(20), 30857–5 (2020).